Protagenic Therapeutics, Inc.\new (PTIX) › Operating IncomeProtagenic Therapeutics, Inc.\new (PTIX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$292.1K2015: -$1.03M2016: -$2.23M2017: -$2.37M2018: -$2.31M2019: -$2.09M2020: -$2.55M2021: -$4.14M2022: -$3.56M2023: -$4.53M2024: -$5.70M-$5.70M2014Operating Income (USD)2024Fiscal YearOperating IncomeChange YoY2024-$5.70M-25.9%2023-$4.53M-27.2%2022-$3.56M+14.1%2021-$4.14M-62.3%2020-$2.55M-22.3%2019-$2.09M+9.9%2018-$2.31M+2.2%2017-$2.37M-5.9%2016-$2.23M-117.9%2015-$1.03M-250.9%2014-$292.1K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share